Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation [clinicaltrials:NCT00863213]

Bio2RDF uri

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation [clinicaltrials:NCT00863213]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00863213

Bio2RDF identifier

NCT00863213

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00863213

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00863213

acronym [clinicaltrials_vocabulary:acronym]

SARA

http://www.w3.org/2001/XMLSchema#string

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

152

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT00863213 arm group 2088bf20304b05053f7756554ae16dc8 [clinicaltrials_resource:NCT00863213/arm-group/2088bf20304b05053f7756554ae16dc8]

NCT00863213 arm group 9b12e6d2c57c8efd0c6f0945f3524594 [clinicaltrials_resource:NCT00863213/arm-group/9b12e6d2c57c8efd0c6f0945f3524594]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:9b0caf6aeabb732d004c463e19234ce6

brief summary [clinicaltrials_vocabulary:brief-summary]

The purpose of this stu ...... rsistent atrial fibrillation.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:f75a4b1baeb97f435a801d22187e6aca]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:0a2847ee719e60b1e20c12546fdc3bbb]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:22b0b4b2afd3e376a90045049a7c8665]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:5f6937639d59e02c890bec526b79f374]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:64459008fc358328926761ef45bfefdd]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:6f3abaa38be7287fc61e043246a5b2fa]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:9b225855776fe86b94bf13e8218da906]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:9b96bf664ad55fbd44e9fda3f2ee3273]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:bf93246aeb0b75c12aa683be2a0d797e]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:f8148657f8dc241b9ec16ae41d921e9d]

Freedom from atrial arrhythmias, lasting more than 24 hours or requiring cardioversion. 1-year follow-up [clinicaltrials_resource:f9b6d6d54412fd662174f0fd79735ac9]

collaborator [clinicaltrials_vocabulary:collaborator]

Hospital Clinic of Barcelona [clinicaltrials_resource:6358233b1e7d609eb62730831c9c3446]

completion date [clinicaltrials_vocabulary:completion-date]

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00863213 [clinicaltrials_resource:8abacda6f5409e4fb0169ee6d91d4d7a]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2009-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Atrial fibrillation ablation [clinicaltrials_resource:4bcc79a7d97deacbaf3514b6bac35962]

Antiarrhythmic drug [clinicaltrials_resource:a9b6947f86b7ed3d9a815c9c932ab471]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Anti-Arrhythmia Agents [clinicaltrials_resource:d221c35e3b6d4d778a1bb0bde05a8174]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Antiarrhythmic Drugs

http://www.w3.org/2001/XMLSchema#string

Atrial fibrillation

http://www.w3.org/2001/XMLSchema#string

Catheter Ablation, Radiofrequency

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Hospital Clinic of Barcelona [clinicaltrials_resource:6358233b1e7d609eb62730831c9c3446]

location [clinicaltrials_vocabulary:location]

Hospital de Cruces [clinicaltrials_resource:c2132ba9496154548ec6d124e7dd6037]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00863213

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

SARA-08

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Lluís Mont, MD [clinicaltrials_resource:a422d7a2119c70ae918b856509d8f382]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Spain: Comité Ético de Investigación Clínica [clinicaltrials_resource:e93e5945f5497361b9a4c9b309f16953]

phase [clinicaltrials_vocabulary:phase]

Phase 4 [clinicaltrials_resource:ec41833bc88cd90619c4d85c549688bd]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:b17c886b08f2aee3825048685d592db4]

secondary id [clinicaltrials_vocabulary:secondary-id]

EudraCT: 2008-006095-30

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Hospital Clinic of Barcelona [clinicaltrials_resource:6358233b1e7d609eb62730831c9c3446]

start date [clinicaltrials_vocabulary:start-date]

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00863213 study design [clinicaltrials_resource:f14e124a0cb8060226f9588e8e709856]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00863213

verification date [clinicaltrials_vocabulary:verification-date]

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00863213

http://www.w3.org/2001/XMLSchema#string

title

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]